Medical Equipment

Neurovascular Embolization Devices Market Insights Highlighting Opportunities Supporting Growth To 2030

April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Neurovascular Embolization Devices Market Over The 2026–2030 Period? _x000D_

The neurovascular embolization devices market size has experienced strong growth over recent years. It is projected to increase from $1.38 billion in 2025 to $1.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to the rising prevalence of cerebral aneurysms, the expansion of neurointerventional procedures, the increasing availability of skilled neurovascular specialists, growing hospital investments in advanced neurocare, and the wider adoption of minimally invasive stroke treatments._x000D_

_x000D_

The neurovascular embolization devices market is projected to experience substantial expansion over the upcoming years. This market is set to reach a value of $1.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. The anticipated growth during this period stems from several factors, including the escalating demand for sophisticated stroke management solutions, increased investments in neurovascular research and development, an expanding elderly demographic experiencing vascular disorders, the rising uptake of cutting-edge embolization devices, and a greater emphasis on enhancing procedural results. Key trends expected over the forecast period encompass a broader adoption of flow diversion stents, the increased utilization of liquid embolic systems, a growing inclination towards minimally invasive neurointerventions, the evolution of coil technologies featuring advanced coatings, and a heightened focus on precise neurovascular devices._x000D_

_x000D_

#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_

https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report_x000D_

_x000D_

Which Primary Drivers Are Impacting The Neurovascular Embolization Devices Market Growth?_x000D_

The anticipated increase in hemorrhage cases is projected to drive the neurovascular embolization devices market in the future. Hemorrhages refer to atypical, unmanaged bleeding occurring either internally within the body or externally via a rupture in the skin or mucous membrane. Various factors contribute to the widespread occurrence of hemorrhages, including an aging demographic, a heightened rate of hypertension, and the broader application of anticoagulant drugs. Neurovascular embolization devices are employed in hemorrhagic strokes to block atypical blood vessels, thereby lessening bleeding and averting additional brain harm. As an illustration, research from King’s College London, a public research university located in the UK, indicated in February 2024 that both occurrences and fatalities from intracerebral hemorrhage (ICH), a particular form of hemorrhage, are predicted to rise by 59.4% among individuals aged 70 to 95 throughout the UK by the year 2050. Consequently, the growing incidence of hemorrhages stimulates expansion within the neurovascular embolization devices market._x000D_

_x000D_

How Is The Neurovascular Embolization Devices Market Broken Down By Segment Categories?_x000D_

The neurovascular embolization devices market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products_x000D_

2) By Treatment: Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions_x000D_

3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications_x000D_

4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings_x000D_

2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System_x000D_

3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment_x000D_

4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips_x000D_

5) By Other Products: Balloons For Embolization, Microcatheters_x000D_

_x000D_

Which Trends Are Shaping Growth In The Neurovascular Embolization Devices Market?_x000D_

Leading companies operating in the neurovascular embolization devices market are concentrating on developing advanced solutions, such as next-generation flow diverters, to supersede conventional aneurysm treatment methods. A next-generation flow diverter is a device engineered to enhance procedural safety and efficacy by improving vessel wall apposition, lowering clotting risk, and facilitating simpler deployment in intricate aneurysm anatomies. For instance, in July 2025, Stryker Corporation, a US-based medical technology company, introduced the Surpass Elite Flow Diverter into its neurovascular portfolio. This innovation aims to replace older aneurysm treatment devices by offering minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It provides enhanced thrombo-resistance and an optimized braid design, allowing physicians to achieve improved procedural outcomes with reduced manipulation. Integrated with Stryker’s training and physician support programs, it delivers a seamless clinical experience. The Surpass Elite Flow Diverter contributes to improved patient safety, streamlined procedural workflow, and aids in expanding the adoption of flow diversion therapy within neurovascular care._x000D_

_x000D_

Which Players Are Present In The Neurovascular Embolization Devices Market Space?_x000D_

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc _x000D_

_x000D_

#Get The Full Neurovascular Embolization Devices Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report_x000D_

_x000D_

Which Geographic Region Dominates The Neurovascular Embolization Devices Market?_x000D_

North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized Neurovascular Embolization Devices Market Report For Competitive Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Neurovascular Embolization Devices Market 2026, By The Business Research Company#_x000D_

_x000D_

Tumor Embolization Devices Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report_x000D_

_x000D_

Transcatheter Embolization And Occlusion Devices Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report_x000D_

_x000D_